Causative agents of osteomyelitis induce death domain-containing TNF-related apoptosis-inducing ligand receptor expression on osteoblasts

Bone

Volumn 48, Issue 4, 2011, Pages 857-863

  Young, Amy B ^a   Cooley, Ian D ^a   Chauhan, Vinita S ^a   Marriott, Ian ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Apoptosis; Osteoblasts; Osteomyelitis; Staphylococcus aureus; TRAIL

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOMYELITIS; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SALMONELLA; SALMONELLOSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; FLOW CYTOMETRY; HUMANS; MICE; OSTEOBLASTS; OSTEOMYELITIS; POLYMERASE CHAIN REACTION; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79952695473     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.11.015     Document Type: Article

References (47)

1. Marriott I., Miller J.R., Sahraei M. Therapeutic strategies against inflammation and bone loss associated with osteomyelitis. Curr Opin Investig Drugs 2007, 8:887-898.
2. Tucker K.A., Reilly S.S., Leslie C.S., Hudson M.C. Intracellular Staphylococcus aureus induces apoptosis in mouse osteoblasts. FEMS Microbiol Lett 2000, 186:151-156.
3. Alexander E.H., Rivera F.A., Marriott I., Anguita J., Bost K.L., Hudson M.C. Staphylococcus aureus-induced tumor necrosis factor-related apoptosis-inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiol 2003, 3:5.
4. Nair S.P., Meghji S., Wilson M., Reddi K., White P., Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996, 64:2371-2380.
5. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T., et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994, 1:131-136.
6. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells 1994, 12:440-455.
7. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962.
8. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., et al. The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
9. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997, 7:831-836.
10. Emery J.G., McDonnell P., Burke M.B., Deen K.C., Lyn S., Silverman C., et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998, 273:14363-14367.
11. Clancy L., Mruk K., Archer K., Woelfel M., Mongkolsapaya J., Screaton G., et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA 2005, 102:18099-180104.
12. Atkins G.J., Bouralexis S., Evdokiou A., Hay S., Labrinidis A., Zannettino A.C., et al. Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 2002, 31:448-456.
13. Bu R., Borysenko C.W., Li Y., Cao L., Sabokbar A., Blair H.C. Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone 2003, 33:760-770.
14. Alexander E.H., Bento J.L., Hughes F.M., Marriott I., Hudson M.C., Bost K.L. Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun 2001, 69:1581-1586.
15. Tinhofer I., Biedermann R., Krismer M., Crazzolara R., Greil R. A role of TRAIL in killing osteoblasts by myeloma cells. FASEB J 2006, 20:759-761.
16. Gasper N.A., Petty C.C., Schrum L.W., Marriott I., Bost K.L. Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4. Infect Immun 2002, 70:4075-4082.
17. Madrazo D.R., Tranguch S.L., Marriott I. Signaling via Toll-like receptor 5 can initiate inflammatory mediator production by murine osteoblasts. Infect Immun 2003, 71:5418-5421.
18. Bost K.L., Bento J.L., Ellington J.K., Marriott I., Hudson M.C. Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts. Infect Immun 2000, 68:5075-5083.
19. Bost K.L., Bento J.L., Petty C.C., Schrum L.W., Hudson M.C., Marriott I. Monocyte chemoattractant protein-1 expression by osteoblasts following infection with Staphylococcus aureus or Salmonella. J Interferon Cytokine Res 2001, 21:297-304.
20. Bost K.L., Ramp W.K., Nicholson N.C., Bento J.L., Marriott I., Hudson M.C. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis 1999, 180:1912-1920.
21. Marriott I., Rati D.M., McCall S.H., Tranguch S.L. Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge. Infect Immun 2005, 73:2967-2973.
22. Marriott I., Hughes F.M., Bost K.L. Bacterial infection of osteoblasts induces interleukin-1beta and interleukin-18 transcription but not protein synthesis. J Interferon Cytokine Res 2002, 22:1049-1055.
23. Schrum L.W., Bost K.L., Hudson M.C., Marriott I. Bacterial infection induces expression of functional MHC class II molecules in murine and human osteoblasts. Bone 2003, 33:812-821.
24. Schrum L.W., Marriott I., Butler B.R., Thomas E.K., Hudson M.C., Bost K.L. Functional CD40 expression induced following bacterial infection of mouse and human osteoblasts. Infect Immun 2003, 71:1209-1216.
25. Grundle R., Beresford J.N. The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int 1995, 56:S8-S10.
26. Reott M.A., Ritchie-Miller S.L., Anguita J., Hudson M.C. TRAIL expression is induced in both osteoblasts containing intracellular Staphylococcus aureus and uninfected osteoblasts in infected cultures. FEMS Microbiol Lett 2008, 278:185-192.
27. McCall S.H., Sahraei M., Young A.B., Worley C.S., Duncan J.A., Ting J.P., et al. Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. J Bone Min Res 2008, 23:30-40.
28. Wu G.S., Burns T.F., Zhan Y., Alnemri E.S., El-Deiry W.S. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999, 59:2770-2775.
29. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
30. Wada T., Nakashima T., Hiroshi N., Penninger J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006, 12:17-25.
31. Emery J.G., McDonnell P., Burke M.B., Deen K.C., Lyn S., Silverman C., et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998, 273:14363-14367.
32. Atkins G.J., Bouralexis S., Evdokiou A., Hay S., Labrinidis A., Zannettino A.C., et al. Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 2002, 31:448-456.
33. Bu R., Borysenko C.W., Li Y., Cao L., Sabokbar A., Blair H.C. Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone 2003, 33:760-770.
34. Nair S., Song Y., Meghji S., Reddi K., Harris M., Ross A., et al. Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. J Bone Miner Res 1995, 10:726-734.
35. Meghji S., Crean S.J., Hill P.A., Sheikh M., Nair S.P., Heron K., et al. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Br J Rheumatol 1998, 37:1095-1101.
36. Maruyama K., Takada Y., Ray N., Kishimoto Y., Penninger J.M., Yasuda H., et al. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J Immunol 2006, 177:3799-3805.
37. Mori G., Brunetti G., Colucci S., Ciccolella F., Coricciati M., Pignataro P., et al. Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL. J Biol Regul Homeost Agents 2007, 21:105-114.
38. Chung Y.H., Chang E.J., Kim S.J., Kim H.H., Kim H.M., Lee S.B., et al. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. J Periodontal Res 2006, 41:288-296.
39. Mori G., Brunetti G., Colucci S., Oranger A., Ciccolella F., Sardone F., et al. Osteoblast apoptosis in periodontal disease: role of TNF-related apoptosis-inducing ligand. Int J Immunopathol Pharmacol 2009, 22:95-103.
40. Somayaji S.N., Ritchie S., Sahraei M., Marriott I., Hudson M.C. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun 2008, 76:5120-5126.
41. Vitovski S., Phillips J.S., Sayers J., Croucher P.I. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. J Biol Chem 2007, 282:31601-31609.
42. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327.
43. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
44. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
45. Dowds T.A., Masumoto J., Zhu L., Inohara N., Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 2004, 279:21924-21928.
46. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006, 281:36560-36568.
47. Gumucio D.L., Diaz A., Schaner P., Richards N., Babcock C., Schaller M., et al. Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002, 20:S45-S53.